Single-Crystal X-ray Diffraction (SCXRD)

Single-crystal X-ray diffraction (SCXRD) is a high-resolution structural biology technique used to determine the three-dimensional atomic arrangement of crystalline molecules. The method involves exposing a single crystal of the target molecule (e.g., a protein or protein-ligand complex) to an X-ray beam. As X-rays interact with the electron density of the atoms in the crystal, they diffract in specific directions, producing a unique diffraction pattern. By measuring the intensity and angles of these diffracted X-rays, researchers can reconstruct an electron density map using computational algorithms such as Fourier transformation. This map is then refined to generate an atomic-level model of the molecule, revealing precise structural details, including bond lengths, angles, and intermolecular interactions. SCXRD is particularly valuable in drug discovery, as it provides unambiguous insights into how small-molecule hits bind to their biological targets.

Applications in High-Throughput Screening (HTS)

In the early stages of drug discovery, identifying high-quality "hits"—small molecules that bind to a target protein—is crucial for developing effective lead compounds. SCXRD plays a pivotal role in hit-to-lead optimization by enabling researchers to visualize the exact binding modes of these hits within the protein's active site. By co-crystallizing the target protein with potential hit molecules and solving their structures, scientists can identify key interactions (e.g., hydrogen bonds, hydrophobic contacts, and conformational changes) that contribute to binding affinity and selectivity. This structural information guides medicinal chemists in refining hit compounds into optimized leads with improved potency, reduced off-target effects, and enhanced drug-like properties. Additionally, SCXRD helps eliminate false positives by confirming true binding events, ensuring that only the most promising candidates advance to further development.

SCXRD offers unparalleled resolution, often achieving atomic-level precision (≤1.5 Å), which is superior to other structural techniques such as NMR spectroscopy or cryo-electron microscopy (cryo-EM). This high resolution allows for the visualization of fine structural details, including water molecules, ions, and subtle protein conformational changes, all of which are critical for rational drug design. Unlike surface-based binding assays (e.g., SPR or ITC), SCXRD provides direct, unambiguous evidence of binding interactions, eliminating ambiguity in hit validation. The technique is versatile and applicable to a wide range of targets, including soluble proteins, membrane proteins (with optimized crystallization strategies), and even fragment-sized molecules. Furthermore, advancements in synchrotron radiation sources, robotic crystallization platforms, and automated data processing have significantly improved throughput, making SCXRD feasible for high-throughput hit screening in early-stage drug discovery.

PharmaAnalytica's Technology Platform

PharmaAnalytica's HIT Screening Services with SCXRD

Single-crystal X-ray diffraction (SCXRD) is a cornerstone technology in early drug discovery, offering unmatched structural insights for hit identification and optimization. STEMart combines cutting-edge SCXRD capabilities with expert service to empower researchers in efficiently advancing their drug development pipelines.

High-Quality Structural Data

PharmaAnalytica employs state-of-the-art X-ray diffraction systems and synchrotron beamlines to deliver high-resolution crystal structures. Our team of crystallography experts ensures rigorous data validation, providing clients with reliable structural models for informed decision-making.

Customized Hit Screening Solutions

We offer tailored SCXRD services to meet specific project needs, from fragment-based screening to hit validation and lead optimization. Our platform supports diverse target classes, including challenging proteins like GPCRs, kinases, and viral proteases, with specialized crystallization and data collection protocols.

Integrated Drug Discovery Support

Beyond SCXRD, STEMart provides complementary services such as molecular docking, structure-activity relationship (SAR) analysis, and medicinal chemistry consultation. This integrated approach accelerates hit-to-lead optimization, reducing both time and costs for clients.

Fast Turnaround and Cost Efficiency

By leveraging automated data collection pipelines and advanced computational tools, we deliver rapid structural insights without compromising accuracy. Our flexible service models ensure cost-effective access to high-end crystallography, making SCXRD accessible to both academic researchers and pharmaceutical companies.

By leveraging our high-resolution structural data, customized solutions, and integrated support, clients can accelerate the transition from hit compounds to viable lead candidates with confidence.